title: Origin and spread of the 1278insTATC mutation causing Tay-Sachs disease in Ashkenazi Jews: genetic drift as a robust and parsimonious hypothesis.
abstract: The 1278insTATC is the most prevalent beta-hexosaminidase A ( HEXA) gene mutation causing Tay-Sachs disease (TSD), one of the four lysosomal storage diseases (LSDs) occurring at elevated frequencies among Ashkenazi Jews (AJs). To investigate the genetic history of this mutation in the AJ population, a conserved haplotype (D15S981:175-D15S131:240-D15S1050:284-D15S197:144-D15S188:418) was identified in 1278insTATC chromosomes from 55 unrelated AJ individuals (15 homozygotes and 40 heterozygotes for the TSD mutation), suggesting the occurrence of a common founder. When two methods were used for analysis of linkage disequilibrium (LD) between flanking polymorphic markers and the disease locus and for the study of the decay of LD over time, the estimated age of the insertion was found to be 40+/-12 generations (95% confidence interval: 30-50 generations), so that the most recent common ancestor of the mutation-bearing chromosomes would date to the 8th-9th century. This corresponds with the demographic expansion of AJs in central Europe, following the founding of the Ashkenaz settlement in the early Middle Ages. The results are consistent with the geographic distribution of the main TSD mutation, 1278insTATC being more common in central Europe, and with the coalescent times of mutations causing two other LSDs, Gaucher disease and mucolipidosis type IV. Evidence for the absence of a determinant positive selection (heterozygote advantage) over the mutation is provided by a comparison between the estimated age of 1278insTATC and the probability of the current AJ frequency of the mutant allele as a function of its age, calculated by use of a branching-process model. Therefore, the founder effect in a rapidly expanding population arising from a bottleneck provides a robust parsimonious hypothesis explaining the spread of 1278insTATC-linked TSD in AJ individuals.
authors.affiliation: Felsenstein Medical Research Center, Rabin Medical Center, 49100, Petah Tikva, Israel. afrisch@post.tau.ac.il
authors.forename: Amos
authors.initials: A
authors.lastname: Frisch
authors.forename: Roberto
authors.initials: R
authors.lastname: Colombo
authors.forename: Elena
authors.initials: E
authors.lastname: Michaelovsky
authors.forename: Mazal
authors.initials: M
authors.lastname: Karpati
authors.forename: Boleslaw
authors.initials: B
authors.lastname: Goldman
authors.forename: Leah
authors.initials: L
authors.lastname: Peleg
mesh_terms: D000483:Alleles; D002884:Chromosomes, Human, Pair 15 / Q000235:genetics; D005060:Europe; D005260:Female; D018703:Founder Effect; D040961:Genetic Drift; D005828:Genetics, Population; D006239:Haplotypes; D054818:Hexosaminidase A; D049690:History, Ancient; D049691:History, Medieval; D006801:Humans; D007585:Jews / Q000235:genetics* / Q000266:history; D015810:Linkage Disequilibrium; D008297:Male; D008957:Models, Genetic; D009154:Mutation; D012641:Selection, Genetic; D013661:Tay-Sachs Disease / Q000201:enzymology* / Q000235:genetics* / Q000266:history; D001619:beta-N-Acetylhexosaminidases / Q000172:deficiency / Q000235:genetics*
chemical_list: D054818:Hexosaminidase A; D001619:beta-N-Acetylhexosaminidases